Pulse Biosciences (PLSE) Change in Account Payables (2015 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Change in Account Payables of -$186000.0 in Q4 2025, down 167.88% quarter-over-quarter from $274000.0 in Q3 2025, and down 2557.14% on a YoY basis from $7569.8 in Q4 2024.
Pulse Biosciences (PLSE) Change in Account Payables (2015 - 2025) Analysis & Trends
Pulse Biosciences' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$186000.0 for Q4 2025.
- In Q4 2025, Change in Account Payables fell 2557.14% year-over-year to -$186000.0; the TTM figure through Dec 2025 stood at $1.1 million (up 663.18% YoY), while the FY2025 annual figure was $1.1 million, up 663.18% from the prior year.
- Change in Account Payables was -$186000.0 for Q4 2025 at Pulse Biosciences, down from $274000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $712000.0 in Q1 2025 to a low of -$1.5 million in Q2 2022.
- Historically, Change in Account Payables has averaged $52500.0 across 5 years, with a median of $64000.0 in 2022.
- The sharpest annual moves came in 2021 and 2025: Change in Account Payables surged 6855.56% in 2021, then tumbled 2557.14% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $185000.0 in 2021, then tumbled by 321.08% to -$409000.0 in 2022, then jumped by 206.85% to $437000.0 in 2023, then plunged by 101.6% to -$7000.0 in 2024, then sank by 2557.14% to -$186000.0 in 2025.
- The last three Change in Account Payables figures came in at -$186000.0 (Q4 2025), $274000.0 (Q3 2025), and $332000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 73.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 6.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 23.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.93 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 102.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | -186,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -186,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Sep 30, 2023 | -386,000.00 |
| Sep 30, 2023 | -386,000.00 |